Dihydroxyphenylalanine [dihydroxyfenylalanin]
topical
101
- Terms
-
3,4-dihydroxyfenylalanin
beta-hydroxytyrosin
DOPA
hydrochlorid dihydroxyfenylalaninu, (2:1)
-
3-Hydroxy-DL-tyrosine
3,4-Dihydroxyphenylalanine
beta-Hydroxytyrosine
Dihydroxyphenylalanine Hydrochloride, (2:1)
Dopa
Persistent link
https://www.medvik.cz/link/D004295
Definition
A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
- Annotation
- check text to see if LEVODOPA; (L-DOPA); is not meant instead
- DUI
- D004295 MeSH Browser
- CUI
- M0006754
- CAS
- DL-Tyrosine, 3-hydroxy-
- History note
- 2002(1966); for BETA-HYDROXYTYROSINE use DIHYDOXYPHENYLALANINE (NM) 1989-1991
- Public note
- 2002; see DOPA 1966-2001
Allowable subheadings
- AD
- administration & dosage 20
- AE
- adverse effects 9
- AG
- agonists 0
- AA
- analogs & derivatives 7
- AN
- analysis 2
- AI
- antagonists & inhibitors 1
- BI
- biosynthesis 1
- BL
- blood 3
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 2
- CH
- chemistry 2
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 1
- ME
- metabolism 11
- PK
- pharmacokinetics 3
- PD
- pharmacology 13
- PH
- physiology 1
- PO
- poisoning 0
- RE
- radiation effects 1
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 30
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records